Cost: $5 - $10 Suggested Donation at the door / Pay as you go
Specials: $3 Blue Moon, Coors Light and Yards, $4 Select Wines, $5 Specialty Cocktails (One themed blue drink TBD)
*Free First Drink for all Dads*
Entertainment: Rich Baker and DJ Mont1
As most of you know Center City SIPS has begun. What some of you may not know is that I'm the Corporate Sponsorship Committee chair for the Prostate Cancer Foundation. I'm excited to invite all of you to one of our events celebrating fathers. We'll be partnering with Public House during Center City SIPS next Wednesday to have fun and raise money for life saving cancer research. I've pasted an excerpt from our site below as well as a link if you'd like to know more about what we do. Hoping to see you all out!
Prostate Cancer Foundation Homepage
Firmly committed to curing prostate cancer, the Prostate Cancer Foundation is the leading philanthropic organization funding and accelerating research globally.
Since 1993, our unique strategies for identifying and investing in the most promising research programs have generated life-saving results. We channel resources to the world’s top scientific minds—cutting red tape and encouraging collaboration to speed breakthroughs.
As a champion for increased government and private support, PCF has helped build a global research enterprise of nearly $10 billion. Through the generous contributions of our donors, we have funded more than 1,600 programs at nearly 200 research centers in 16 countries.
The Reliable Source for the Latest Developments
For more than 16 million men and their families fighting prostate cancer globally, PCF is a primary source for new standard-of-care and research information. We connect patients, loved ones, care providers and scientists to critical updates, the latest developments, best practices and news from the treatment pipeline.
Advancing Hope, with Your Help
Many important discoveries in the fight against prostate cancer since 1993 resulted from PCF funding or coordination—including the development of new medications, gene therapy approaches and the development of vaccines that may soon work with the body’s immune system to kill prostate cancer cells.
Thanks to these and other victories, the U.S. death rate from prostate cancer has dropped nearly 40% from what was once projected. But much more work remains—and we must intensify our efforts now. Too many men still die from prostate cancer; too many families still suffer.